세계 안내 렌즈(IOL) 시장 규모는 2024년 44억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 65억 달러에 달할 것으로 예상하며, 2025-2033년 연평균 성장률(CAGR)은 4.31%를 보일 것으로 전망하고 있습니다. 북미가 2024년 시장을 독점하고 있으며, 이는 첨단 의료 인프라와 지속적인 기술 혁신에 힘입은 바 큽니다. 백내장 발병률 증가와 함께 고령화 인구 증가, 안과 의료에 대한 전 세계적인 인식과 접근성 향상으로 인해 고급 수술적 개입에 대한 수요가 증가하면서 안내 렌즈(IOL) 시장 점유율을 견인하고 있습니다.
시장은 다초점 렌즈 및 토릭 렌즈와 같은 고급 시력 교정 옵션에 대한 환자들의 인식이 높아짐에 따라 시장을 주도하고 있습니다. 특히 장시간의 스크린 노출로 인한 생활습관 관련 안질환 증가는 수술적 개입이 필요한 시력 장애의 원인이 되고 있습니다. 안과 수술에 대한 보험 적용과 유리한 상환 정책 증가로 인해 더 많은 사람들이 안내 렌즈(IOL)를 더 쉽게 이용할 수 있게 되었습니다. 또한, 젊은 층의 선택적 시력교정을 위한 굴절교정렌즈 교체 추세는 시장의 저변을 넓히고 있습니다. 첨단 안내 렌즈(IOL)의 장점을 강조하는 제조업체와 안과의사들의 마케팅 활동도 환자들의 선택에 영향을 미치고 있습니다. 또한, 수술의 안전성과 치료 성적이 향상됨에 따라 더 많은 사람들이 렌즈 교체 수술을 선택하도록 유도하고 있습니다.
백내장 유병률 증가
특히 고령화 사회에서 백내장 유병률 증가는 시장의 주요 촉진요인입니다. 미국 질병예방통제센터(CDC)에 따르면, 2028년까지 미국에서 3,000만 명 이상이 백내장에 걸릴 것으로 예측됩니다. 백내장은 수정체의 혼탁을 일으켜 시력장애를 유발하며, 수술로만 교정할 수 있습니다. 전 세계적으로 노인 인구가 증가함에 따라 백내장 수술 건수가 크게 증가하여 안내 렌즈(IOL) 수요를 견인하고 있습니다. 백내장 수술을 무료로 제공하거나 보조금을 지급하는 공중 보건 노력과 정부 프로그램 덕분에 백내장 수술이 더욱 친근하게 다가오고 있습니다. 수술 기술의 향상과 성공률 증가로 백내장 제거를 선택하는 환자가 증가하면서 전 세계적으로 안내 렌즈(IOL)의 보급에 직접적인 영향을 미치고 있습니다.
안과 의료센터 확장
안과 의료 센터의 확장은 전문적인 안과 치료에 대한 접근성을 향상시키는 데 도움이 되고 있습니다. 2025년 7월, D. 라마무르시 회장 겸 사장이 설립한 초전문 안과 병원 네트워크인 아이재단은 인도 첸나이 바다팔라니에 25번째 병원을 개원했습니다. 이 센터에서는 프리미엄 안내 렌즈(IOL)를 이용한 레이저 백내장 수술과 SILK, Femto와 같은 최첨단 라식 기술 등 전문적인 서비스를 제공합니다. 도시와 농촌을 막론하고 더 많은 병원 및 진료소, 안과 전용 시설이 개설되어 더 많은 사람들이 백내장 및 굴절교정수술을 받을 수 있게 되었습니다. 이러한 인프라의 개선은 백내장과 같이 외과적 개입이 필요한 질환에 있어 매우 중요한 적시 진단과 치료를 가능하게 합니다. 첨단 의료센터의 존재는 수술에 대한 환자의 신뢰를 높이고 시력교정술을 선택하는 개인을 늘리고 있습니다.
기술 발전
기술의 발전은 환자에게 더 나은 시각적 결과와 맞춤형 선택권을 제공함으로써 시장 성장을 가속하고 있습니다. 다초점 렌즈, 초점심도 확대 렌즈, 토릭 렌즈, 수용형 안내 렌즈(IOL) 등의 기술 혁신으로 노안 및 난시 교정 효과가 향상되어 안경에 대한 의존도가 낮아지고 있습니다. 렌즈 소재의 발전으로 생체적합성이 향상되어 수술 후 합병증이 감소하는 한편, 펨토세컨드 레이저 지원 백내장 수술과 같은 정밀 수술 기술로 이식 정확도가 향상됩니다. 2025년 1월, Yebright Medical Technology(Beijing) Co., Ltd.는 자회사와 함께 자사의 안내 렌즈 'Loong Crystal PR'이 국가의료제품관리국(NMPA)으로부터 Class III 의료기기 인증서를 획득했다고 발표했습니다. 획득했다고 발표했습니다. 고급스럽고 균형 잡힌 아크릴 소재로 제작된 Loong Crystal PR은 광범위한 광학 영역과 안정적인 이중 오목한 아치형 높이 구성의 제로 구면 수차 레이아웃이 특징입니다. 여기에 디지털 이미지와 인공지능(AI) 기반 계획 도구의 통합을 통해 외과의사는 환자 개개인의 필요에 따라 최적의 굴절교정 결과를 얻을 수 있습니다.
생활습관 관련 안과 질환 급증
장시간 스크린 사용으로 인한 생활습관 관련 안질환 발생률이 증가하고 있으며, 시장 전망은 양호합니다. 컴퓨터, 스마트폰, 디지털 기기의 과도한 사용은 눈의 피로, 안구건조증, 시력저하를 가속화하고, 렌즈 관련 질환의 조기 발병에 기여하고 있습니다. 기존에는 노년층이 겪던 시력장애를 젊은 층이 경험하게 되면서 안내 렌즈(IOL) 수술의 잠재적 환자층이 확대되고 있습니다. 또한, 지속적으로 블루라이트에 노출되고 야외활동이 줄어들면 눈 건강 전반에 영향을 미치는 것으로 알려져 있으며, 교정수술이 필요한 것으로 알려져 있습니다. 안과 전문의들은 시력 회복을 위해 적시에 수술적 개입을 권장하고 있으며, 여기에는 종종 고급 안내 렌즈(IOL) 이식이 포함됩니다. 이러한 라이프스타일의 변화는 안과 교정 수술에 대한 지속적인 수요를 자극하고 시장 성장을 가속하고 있습니다.
고급 시력 교정 옵션에 대한 인식 증가
고급 시력 교정 옵션에 대한 인식이 높아지면서 안내 렌즈(IOL)에 대한 수요가 증가하고 있습니다. 교육 프로그램과 소셜 미디어를 통해 백내장 수술과 굴절교정 렌즈 교체에 대한 지식을 넓혀가고 있습니다. 많은 사람들이 안내 렌즈(IOL)는 백내장뿐만 아니라 근시, 원시, 난시 등의 굴절이상도 교정할 수 있다는 것을 알고 있습니다. 입소문을 통한 추천, 체험담, 안과 의사의 투명한 소통은 이러한 수술에 대한 신뢰를 더욱 높여주고 있습니다. 환자들이 안경에 대한 의존도를 줄일 수 있는 프리미엄 렌즈를 사용할 수 있다는 사실을 알게 되면서, 수술적 개입을 조기에 선택할 가능성이 높아지고 있습니다. 이러한 인식 증가는 건강에 대한 인식 증가와 맞물려 채택률 향상과 직결되어 시장의 꾸준한 성장을 견인하고 있습니다.
안과 치료에 대한 보험 적용 확대
안과 치료에 대한 보험 적용 증가는 시력교정수술에 대한 경제적 장벽을 크게 낮추기 때문에 시장에 긍정적인 영향을 미치고 있습니다. 많은 건강 보험은 안내 렌즈(IOL) 비용을 포함한 백내장 수술 비용의 일부 또는 전액을 보상합니다. 이를 통해 은퇴자나 저소득층 환자 등 더 많은 계층이 고급 렌즈를 쉽게 이용할 수 있게 되었습니다. 또한 일부 국가에서는 시력 상실을 예방하고 삶의 질을 향상시키기 위해 적시에 수술을 받도록 장려하고 있습니다. 보험 적용으로 본인부담금이 줄어들기 때문에 환자들은 시력이 향상된 고급 안내 렌즈(IOL)를 선택할 수 있습니다. 이는 시장 침투율을 높일 뿐만 아니라, 수술 건당 평균 수익도 증가시키고 있습니다. 보험제도가 안과 치료에 대한 보험 적용 범위를 지속적으로 확대함에 따라, 안내 렌즈(IOL) 수요는 꾸준히 증가할 것으로 예측됩니다.
The global intraocular lens market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. North America dominates the market in 2024, driven by advanced healthcare infrastructure and continual technological innovations. The growing aging population with increased cataract incidence and rising global awareness and accessibility to eye care are collectively driving the demand for advanced surgical interventions, thereby propelling the intraocular lens market share.
The market is driven by the growing awareness among patients about advanced vision correction options, such as multifocal and toric lenses. Rising lifestyle-related eye conditions, particularly due to prolonged screen exposure, are contributing to vision impairments requiring surgical intervention. Increasing insurance coverage and favorable reimbursement policies for eye surgeries are making IOLs more accessible to a broader population. Additionally, the trend of refractive lens exchange for elective vision correction among younger individuals is widening the market base. Greater marketing efforts by manufacturers and ophthalmologists to highlight the benefits of advanced IOLs are also influencing patient choices. Furthermore, improvements in surgical safety and outcomes are encouraging more people to opt for lens replacement procedures.
Increasing prevalence of cataracts
Rising prevalence of cataracts, especially among the aging population, is a major driver for the market. As per the Centers for Disease Control and Prevention (CDC), by the year 2028, it is anticipated that more than 30 Million individuals will be affected by cataracts in the United States. Cataracts cause clouding of the natural lens, leading to vision impairment that can only be corrected through surgery. As the global elderly demographic is growing, the number of cataract surgeries is increasing significantly, driving the demand for IOLs. Public health initiatives and government programs offering free or subsidized cataract surgeries are making treatments more accessible. With improved surgical techniques and higher success rates, more patients are opting for cataract removal, directly fueling the adoption of IOLs worldwide.
Expansion of ophthalmic care centers
The broadening of ophthalmic care centers is aiding in improving accessibility to specialized eye treatments. In July 2025, the Eye Foundation, a network of super-speciality eye hospitals established by D. Ramamurthy, chairman and managing director, inaugurated its 25th facility in Vadapalani, Chennai, India. The center provided specialized services, such as laser cataract surgery featuring premium IOLs and cutting-edge LASIK technologies like SILK and Femto. With more hospitals, clinics, and dedicated eye care facilities opening in both urban and rural areas, a larger population can undergo cataract and refractive surgeries. This improved infrastructure enables timely diagnosis and treatment, which is crucial for conditions like cataracts that require surgical intervention. The presence of advanced care centers is boosting patient confidence in surgical procedures, encouraging more individuals to opt for vision correction.
Technological advancements
Technological advancements are propelling the market growth by offering patients improved visual outcomes and greater customization options. Innovations, such as multifocal, extended depth-of-focus, toric lenses, and accommodating IOLs, provide better correction for presbyopia and astigmatism, reducing dependence on glasses. Advancements in lens materials enhance biocompatibility and reduce post-surgical complications, while precision surgical techniques like femtosecond laser-assisted cataract surgery increase implantation accuracy. In January 2025, Yebright Medical Technology (Beijing) Co., Ltd., along with its subsidiaries, declared that its Phakic IOL, 'Loong Crystal PR,' obtained the Class III Medical Devices Certificate from the National Medical Products Administration (NMPA). Made from an advanced, balanced acrylic material, the Loong Crystal PR featured a zero spherical aberration layout with an extensive optical zone and a stable double concave arch height configuration. Besides this, the integration of digital imaging and artificial intelligence (AI)-based planning tools allows surgeons to achieve optimal refractive results tailored to individual patient needs.
Surge in lifestyle-related eye conditions
Increasing incidence of lifestyle-related eye conditions caused by prolonged screen time is offering a favorable market outlook. Excessive use of computers, smartphones, and digital devices leads to eye strain, dry eyes, and accelerated vision deterioration, contributing to the earlier onset of lens-related disorders. Younger individuals are now experiencing vision impairment that traditionally affected older adults, expanding the potential patient base for IOL surgeries. Additionally, constant exposure to blue light and reduced outdoor activities are known to affect overall eye health, necessitating corrective procedures. Eye care professionals are recommending timely surgical interventions to restore vision, which often involve the implantation of advanced IOLs. This lifestyle shift is catalyzing sustained demand for corrective eye surgeries, thereby fueling the market growth.
Growing awareness about advanced vision correction options
Rising awareness about advanced vision correction options is driving the demand for IOLs, as patients are seeking long-term solutions to restore clear vision. Educational programs and social media outreach have made people more informed about cataract surgery and refractive lens exchange. Many individuals are understanding that IOLs not only treat cataracts but can also correct refractive errors like myopia, hyperopia, and astigmatism. Word-of-mouth recommendations, testimonials, and transparent communication from ophthalmologists further build trust in these procedures. As patients are learning about the availability of premium lens types offering reduced dependence on glasses, they are more likely to choose surgical intervention earlier. This heightened awareness, combined with increased health consciousness, is directly translating into higher adoption rates, thereby impelling steady market growth.
Increasing insurance coverage for eye treatments
Rising insurance coverage for eye treatments is positively influencing the market, as it significantly reduces the financial barrier to vision correction surgeries. Many health insurance policies include partial or full coverage for cataract procedures, including the cost of IOLs. This makes advanced lens options more accessible to a broader demographic, including retirees and low-income patients. Reimbursement policies in several countries also encourage timely surgery, preventing vision loss and improving quality of life. By alleviating out-of-pocket expenses, insurance coverage allows patients to opt for premium IOLs with enhanced visual performance. This is not only boosting the market penetration but also increasing the average revenue per surgery. As insurance policies continue to expand their scope for ophthalmic treatments, the demand for IOLs is expected to grow steadily.
Multifocal IOL account for the majority of the market share
Multifocal IOLs dominate the market as the largest segment, offering a comprehensive solution to age-related vision issues. These lenses provide multiple focal points, allowing patients to achieve clear vision at various distances, reducing dependence on glasses after cataract surgery. With an aging population seeking enhanced visual acuity for both near and far distances, multifocal IOLs have gained prominence. The versatility they offer aligns with the lifestyle demands of individuals desiring improved vision across different activities, from reading to driving, making them a preferred choice in the market.
Monofocal IOLs represent a significant segment of the market, serving as a traditional and cost-effective option for cataract surgery. These lenses have a single focal point, typically set for distance vision, necessitating the use of glasses for activities requiring near vision. While lacking multifocal versatility, monofocal IOLs remain popular due to their reliability and affordability, catering to patients with specific visual needs and budget constraints.
Toric IOLs address astigmatism, a common refractive error, making them a crucial segment in the market. These lenses correct both cataracts and astigmatism simultaneously, enhancing visual outcomes for patients with irregular corneal shapes. With an increasing prevalence of astigmatism globally, toric IOLs have witnessed growing demand, offering patients the opportunity to achieve better visual clarity without additional surgical interventions or reliance on corrective eyewear.
Accommodative IOLs represent an innovative segment designed to mimic the eye's natural ability to adjust focus. These lenses provide a dynamic range of vision by changing shape and position within the eye. While still evolving, accommodative IOLs aim to reduce dependency on glasses for both near and distant vision. As technological advancements continue, this segment holds promise for individuals seeking a more adaptive and natural visual experience post-cataract surgery.
Hydrophobic acrylic holds the largest share of the industry
Hydrophobic acrylic has emerged as the largest segment in the market due to its superior optical properties and biocompatibility. These lenses are known for their resistance to protein and water deposits, reducing the likelihood of postoperative complications. Hydrophobic acrylic IOLs provide excellent clarity and are suitable for various surgical techniques. Surgeons often prefer this material for its ease of handling and the reduced risk of posterior capsule opacification (PCO), contributing to the widespread adoption of hydrophobic acrylic lenses in modern cataract surgeries. The material's ability to maintain optical clarity over time and resist clouding has solidified its position as a leading choice.
PMMA has been a traditional material in intraocular lenses (IOLs) and, while its usage has decreased with technological advancements, it still holds a notable segment in the market. PMMA lenses are rigid and durable, providing stability within the eye. However, their lack of flexibility and potential for certain postoperative complications have led to a decline in their popularity compared to more modern materials like hydrophobic acrylic and silicone.
Silicone lenses offer flexibility and biocompatibility, contributing to their prevalence in the market. Known for their softness and ability to fold easily, silicone lenses facilitate less invasive surgical procedures. The material's inert nature reduces the risk of inflammation and allergic reactions. While not as widely used as hydrophobic acrylic, silicone remains a significant choice, particularly in cases where the surgeon prioritizes lens flexibility and patient comfort.
Hospitals represent the leading market segment
Hospitals constitute the largest segment of the market, serving as primary hubs for surgical procedures, including cataract surgeries requiring IOL implantation. The comprehensive infrastructure and diverse medical specialties within hospitals make them central to the diagnosis and treatment of ocular conditions. The high patient footfall in hospitals, coupled with the availability of advanced surgical facilities, positions them as key contributors to the demand for intraocular lenses. Moreover, hospitals often attract a wide range of patients, including those with complex ocular conditions, making them pivotal in the overall market share.
On the other hand, ophthalmic clinics represent a significant segment of the market, offering specialized care focused on eye health. These clinics, led by ophthalmologists and optometrists, are key contributors to the diagnosis and treatment of various eye disorders, including cataracts. Ophthalmic clinics provide a more specialized and focused environment for eye care, attracting patients seeking expert advice and surgical interventions. The efficiency and expertise of these clinics contribute to their substantial share in the IOL market, particularly for routine and elective eye surgeries.
Moreover, ambulatory care centers play a notable role in the market, offering a balance between the comprehensive services of hospitals and the specialized care of ophthalmic clinics. These centers provide outpatient surgical procedures, including cataract surgery with this lens implantation. The convenience of ambulatory care centers, offering timely and efficient procedures without the need for overnight hospital stays, appeals to patients and contributes to the demand for these lenses outside traditional hospital settings.
Furthermore, eye research institutes are crucial contributors to the market. These institutions focus on advancing knowledge in ophthalmology, developing new surgical techniques, and conducting clinical trials for innovative intraocular lens technologies. The insights and advancements generated by eye research institutes influence the broader market, shaping the future of these lens materials, designs, and surgical approaches. While not primary end-users for routine surgeries, these institutes play a pivotal role in driving innovation and elevating the standards of care in the field of ophthalmology.
North America leads the market, accounting for the largest intraocular lens market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America dominates the market, driven by advanced healthcare infrastructure, a high prevalence of cataracts, and a rapidly aging population. The region's well-established reimbursement policies and a strong focus on technological innovations contribute to the widespread adoption of premium IOLs. The presence of key market players, coupled with a proactive approach toward eye health and surgical interventions, solidifies North America's leading position in the global IOL market.
The Asia Pacific region is a significant and growing market for intraocular lenses, fueled by a large population, increasing awareness of eye health, and rising access to healthcare services. The prevalence of age-related eye conditions, including cataracts, in countries like China and India, propels the demand for IOLs. Furthermore, advancements in healthcare infrastructure and the growing disposable income in several Asia Pacific nations contribute to the expansion of the market in the region.
Europe stands as a prominent market for these lenses, driven by a well-established healthcare system, a high prevalence of age-related eye disorders, and a growing emphasis on minimally invasive surgical techniques. The region's aging population contributes significantly to the demand for cataract surgeries and, consequently, intraocular lenses. European countries also exhibit a strong inclination toward adopting innovative medical technologies, fostering the growth of the market in the region.
Latin America represents a burgeoning market for intraocular lenses, propelled by improving healthcare infrastructure and a rising awareness of eye health. The region's aging demographic contributes to an increased incidence of cataracts, driving the demand for lens implantation. While the market is still developing, Latin America showcases substantial growth potential, with increasing investments in healthcare and a growing focus on addressing visual impairments.
The Middle East and Africa exhibit a growing demand for these lenses, driven by improving healthcare accessibility and rising awareness of eye disorders. Although the market is in the early stages of development compared to other regions, an aging population and increasing investments in healthcare infrastructure contribute to the expansion of the market. As these regions continue to advance in medical technology adoption, the demand for intraocular lenses is expected to rise, albeit at a pace influenced by regional economic factors and healthcare development.
The key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. Continuous research and development efforts are directed towards the enhancement of intraocular lens technologies, focusing on improving optical outcomes, durability, and patient satisfaction. Companies are investing in the development of innovative materials and designs, such as advanced hydrophobic acrylics and multifocal lenses, to address evolving patient needs. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent among key players, enabling them to strengthen their product portfolios and leverage complementary technologies. Market leaders are also actively involved in geographic expansion, targeting emerging markets with growing healthcare infrastructures.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: